All In MedTech

Device Trial Radar · NCT02577354

ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain

ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)

Last checked: Nov 19, 2026Latest source record: Feb 27, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 204 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

204

Actual

Start

Aug 2016

Primary completion

Nov 2018

Study completion Jan 2024

Sponsor

Lead sponsor
Mainstay MedicalNot on our public-company list
Sponsor type
Industry
First posted
Oct 16, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 22 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this trial is to evaluate the safety and efficacy of ReActiv8 for the treatment of adults with Chronic Low Back Pain when used in conjunction with medical management.

Conditions

  • Chronic Low Back Pain

Interventions

  • ReActiv8 Implantable Stimulation System (Patient Appropriate Stimulation)Device

    ReActiv8 implanted and configured to deliver stimulation at a patient-appropriate level, and participants instructed to deliver stimulation in two 30-minute sessions per day.

  • ReActiv8 Implantable Stimulation System (Low Stimulation)Device

    ReActiv8 implanted and configured to deliver low stimulation, and participants instructed to deliver stimulation in two 30-minute sessions per day.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Responder Rate of Low Back Pain With No Increase in Pain MedicationsTime frame: 120 Days
  2. Mean Change in Low Back Pain VASTime frame: 120 Days
  3. Cumulative Proportion of Responders Analysis (CPRA) for the Primary Endpoint to Compare Participants Responses Over a Full Range of Response LevelsTime frame: 120 Days

1 more outcomes with a free account

Locations

26 sites in 5 countries. Site status is shown where the registry gives one.

  • University of California, San Diego

    La Jolla, California

  • The Spine Institute

    Santa Monica, California

  • University of Colorado Hospital

    Aurora, Colorado

23 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.